Table 3 Clinical characteristics and biomarkers of patients in the ALD-without-PLC group and ALD-associated-PLC group
variables | ALD-without-PLC | ALD-associated-PLC | P |
|---|---|---|---|
drinking time (years) | 28.91 ± 10.22 | 34.57 ± 9.7 | < 0.01 |
average daily drinking (g/d) | 127.85 ± 80.35 | 175.47 ± 93.07 | < 0.01 |
ALT (U/L) | 47.14 ± 79.31 | 30.98 ± 30.99 | 0.15 |
AST (U/L) | 63.96 ± 99.14 | 44.58 ± 29.47 | 0.01 |
GGT (U/L) | 234.98 ± 322.19 | 136.26 ± 326.18 | 0.05 |
AKP (U/L) | 128.67 ± 96.71 | 139.45 ± 107.05 | 0.48 |
TBIL (umol/L) | 56.93 ± 84.79 | 47.68 ± 83.98 | 0.48 |
DBIL (umol/L) | 34 ± 60.96 | 27.08 ± 58.14 | 0.46 |
PT-INR | 1.4 ± 1.48 | 1.37 ± 0.24 | 0.88 |
AST to ALT ratio | 1.74 ± 0.98 | 1.9 ± 0.71 | 0.41 |
Cho (mmol/L) | 4.1 ± 1.61 | 3.46 ± 1.38 | < 0.01 |
TG (mmol/L) | 1.61 ± 1.99 | 0.82 ± 0.29 | < 0.01 |
HDL-C (mmol/L) | 1.03 ± 0.46 | 1.02 ± 0.42 | 0.92 |
LDL-C (mmol/L) | 2.27 ± 1.22 | 1.9 ± 1.42 | 0.06 |
DF | 7.86 ± 24.49 | 13.49 ± 13.64 | 0.03 |
MELD | 7.81 ± 6.83 | 9.2 ± 4.63 | 0.08 |
ABIC | 6.96 ± 1.71 | 7.74 ± 0.88 | < 0.01 |
GAHS | 6.54 ± 1.01 | 6.75 ± 0.7 | 0.07 |
ABIC score/TG (L/mmol) | 6.59 ± 4.25 | 10.44 ± 3.27 | < 0.01 |